ACFN vs RARE · P/E 22, rev $4.7M vs rev $350.0M
Acorn Energy, Inc. Common Stock (ACFN) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Acorn Energy, Inc. Common Stock (ACFN) is a scientific & technical instruments company listed on NASDAQ.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported ACFN revenue for 2026-06-30 was $4.7M. Net income was $217.0K. ACFN currently screens at market cap $43.0M and trailing P/E 22.3.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
ACFN currently screens at market cap $43.0M and trailing P/E 22.3. RARE currently screens at market cap $2.79B.
Not investment advice. Open the ACFN and RARE stock pages for the full models.
Not investment advice.